IGKV2D-29 and cocaine use disorder: More recently, based on the acute effects of cocaine in the nanomolar range (1–100 nM) in the D2 receptor-Sigma1 receptor complexes, putative A2A-D2 receptor-Sigma1 heteroreceptor complexes appeared to have relevance for the treatment of cocaine use disorder [145].